Table of Content

1 Androgen and Anabolic Steroid Market Overview
1.1 Product Overview and Scope of Androgen and Anabolic Steroid
1.2 Androgen and Anabolic Steroid Segment by Type
1.2.1 Global Androgen and Anabolic Steroid Market Value Comparison by Type (2024-2034)
1.2.2 Testosterone
1.2.3 Methyltestosterone
1.2.4 Fluoxymesterone
1.2.5 Others
1.3 Androgen and Anabolic Steroid Segment by Application
1.3.1 Global Androgen and Anabolic Steroid Market Value by Application: (2024-2034)
1.3.2 Hospitals
1.3.3 Pharmacy
1.3.4 Others
1.4 Global Androgen and Anabolic Steroid Market Size Estimates and Forecasts
1.4.1 Global Androgen and Anabolic Steroid Revenue 2018-2029
1.4.2 Global Androgen and Anabolic Steroid Sales 2018-2029
1.4.3 Global Androgen and Anabolic Steroid Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Androgen and Anabolic Steroid Market Competition by Manufacturers
2.1 Global Androgen and Anabolic Steroid Sales Market Share by Manufacturers (2018-2024)
2.2 Global Androgen and Anabolic Steroid Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Androgen and Anabolic Steroid Average Price by Manufacturers (2018-2024)
2.4 Global Androgen and Anabolic Steroid Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Androgen and Anabolic Steroid, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Androgen and Anabolic Steroid, Product Type & Application
2.7 Androgen and Anabolic Steroid Market Competitive Situation and Trends
2.7.1 Androgen and Anabolic Steroid Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Androgen and Anabolic Steroid Players Market Share by Revenue
2.7.3 Global Androgen and Anabolic Steroid Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Androgen and Anabolic Steroid Retrospective Market Scenario by Region
3.1 Global Androgen and Anabolic Steroid Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Androgen and Anabolic Steroid Global Androgen and Anabolic Steroid Sales by Region: 2018-2029
3.2.1 Global Androgen and Anabolic Steroid Sales by Region: 2018-2024
3.2.2 Global Androgen and Anabolic Steroid Sales by Region: 2024-2029
3.3 Global Androgen and Anabolic Steroid Global Androgen and Anabolic Steroid Revenue by Region: 2018-2029
3.3.1 Global Androgen and Anabolic Steroid Revenue by Region: 2018-2024
3.3.2 Global Androgen and Anabolic Steroid Revenue by Region: 2024-2029
3.4 North America Androgen and Anabolic Steroid Market Facts & Figures by Country
3.4.1 North America Androgen and Anabolic Steroid Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Androgen and Anabolic Steroid Sales by Country (2018-2029)
3.4.3 North America Androgen and Anabolic Steroid Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Androgen and Anabolic Steroid Market Facts & Figures by Country
3.5.1 Europe Androgen and Anabolic Steroid Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Androgen and Anabolic Steroid Sales by Country (2018-2029)
3.5.3 Europe Androgen and Anabolic Steroid Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Androgen and Anabolic Steroid Market Facts & Figures by Country
3.6.1 Asia Pacific Androgen and Anabolic Steroid Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Androgen and Anabolic Steroid Sales by Country (2018-2029)
3.6.3 Asia Pacific Androgen and Anabolic Steroid Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Androgen and Anabolic Steroid Market Facts & Figures by Country
3.7.1 Latin America Androgen and Anabolic Steroid Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Androgen and Anabolic Steroid Sales by Country (2018-2029)
3.7.3 Latin America Androgen and Anabolic Steroid Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Androgen and Anabolic Steroid Market Facts & Figures by Country
3.8.1 Middle East and Africa Androgen and Anabolic Steroid Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Androgen and Anabolic Steroid Sales by Country (2018-2029)
3.8.3 Middle East and Africa Androgen and Anabolic Steroid Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Androgen and Anabolic Steroid Sales by Type (2018-2029)
4.1.1 Global Androgen and Anabolic Steroid Sales by Type (2018-2024)
4.1.2 Global Androgen and Anabolic Steroid Sales by Type (2024-2029)
4.1.3 Global Androgen and Anabolic Steroid Sales Market Share by Type (2018-2029)
4.2 Global Androgen and Anabolic Steroid Revenue by Type (2018-2029)
4.2.1 Global Androgen and Anabolic Steroid Revenue by Type (2018-2024)
4.2.2 Global Androgen and Anabolic Steroid Revenue by Type (2024-2029)
4.2.3 Global Androgen and Anabolic Steroid Revenue Market Share by Type (2018-2029)
4.3 Global Androgen and Anabolic Steroid Price by Type (2018-2029)
5 Segment by Application
5.1 Global Androgen and Anabolic Steroid Sales by Application (2018-2029)
5.1.1 Global Androgen and Anabolic Steroid Sales by Application (2018-2024)
5.1.2 Global Androgen and Anabolic Steroid Sales by Application (2024-2029)
5.1.3 Global Androgen and Anabolic Steroid Sales Market Share by Application (2018-2029)
5.2 Global Androgen and Anabolic Steroid Revenue by Application (2018-2029)
5.2.1 Global Androgen and Anabolic Steroid Revenue by Application (2018-2024)
5.2.2 Global Androgen and Anabolic Steroid Revenue by Application (2024-2029)
5.2.3 Global Androgen and Anabolic Steroid Revenue Market Share by Application (2018-2029)
5.3 Global Androgen and Anabolic Steroid Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Auxilium Pharmaceuticals
6.1.1 Auxilium Pharmaceuticals Corporation Information
6.1.2 Auxilium Pharmaceuticals Description and Business Overview
6.1.3 Auxilium Pharmaceuticals Androgen and Anabolic Steroid Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Auxilium Pharmaceuticals Androgen and Anabolic Steroid Product Portfolio
6.1.5 Auxilium Pharmaceuticals Recent Developments/Updates
6.2 AbbVie
6.2.1 AbbVie Corporation Information
6.2.2 AbbVie Description and Business Overview
6.2.3 AbbVie Androgen and Anabolic Steroid Sales, Revenue and Gross Margin (2018-2024)
6.2.4 AbbVie Androgen and Anabolic Steroid Product Portfolio
6.2.5 AbbVie Recent Developments/Updates
6.3 Teva
6.3.1 Teva Corporation Information
6.3.2 Teva Description and Business Overview
6.3.3 Teva Androgen and Anabolic Steroid Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Teva Androgen and Anabolic Steroid Product Portfolio
6.3.5 Teva Recent Developments/Updates
6.4 GlaxoSmithKline
6.4.1 GlaxoSmithKline Corporation Information
6.4.2 GlaxoSmithKline Description and Business Overview
6.4.3 GlaxoSmithKline Androgen and Anabolic Steroid Sales, Revenue and Gross Margin (2018-2024)
6.4.4 GlaxoSmithKline Androgen and Anabolic Steroid Product Portfolio
6.4.5 GlaxoSmithKline Recent Developments/Updates
6.5 Endo Pharmaceuticals
6.5.1 Endo Pharmaceuticals Corporation Information
6.5.2 Endo Pharmaceuticals Description and Business Overview
6.5.3 Endo Pharmaceuticals Androgen and Anabolic Steroid Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Endo Pharmaceuticals Androgen and Anabolic Steroid Product Portfolio
6.5.5 Endo Pharmaceuticals Recent Developments/Updates
6.6 Pfizer
6.6.1 Pfizer Corporation Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer Androgen and Anabolic Steroid Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Pfizer Androgen and Anabolic Steroid Product Portfolio
6.6.5 Pfizer Recent Developments/Updates
6.7 Acerus Pharmaceuticals
6.6.1 Acerus Pharmaceuticals Corporation Information
6.6.2 Acerus Pharmaceuticals Description and Business Overview
6.6.3 Acerus Pharmaceuticals Androgen and Anabolic Steroid Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Acerus Pharmaceuticals Androgen and Anabolic Steroid Product Portfolio
6.7.5 Acerus Pharmaceuticals Recent Developments/Updates
6.8 Antares Pharma
6.8.1 Antares Pharma Corporation Information
6.8.2 Antares Pharma Description and Business Overview
6.8.3 Antares Pharma Androgen and Anabolic Steroid Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Antares Pharma Androgen and Anabolic Steroid Product Portfolio
6.8.5 Antares Pharma Recent Developments/Updates
6.9 Amneal Pharmaceuticals
6.9.1 Amneal Pharmaceuticals Corporation Information
6.9.2 Amneal Pharmaceuticals Description and Business Overview
6.9.3 Amneal Pharmaceuticals Androgen and Anabolic Steroid Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Amneal Pharmaceuticals Androgen and Anabolic Steroid Product Portfolio
6.9.5 Amneal Pharmaceuticals Recent Developments/Updates
6.10 Solvay Pharmaceuticals
6.10.1 Solvay Pharmaceuticals Corporation Information
6.10.2 Solvay Pharmaceuticals Description and Business Overview
6.10.3 Solvay Pharmaceuticals Androgen and Anabolic Steroid Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Solvay Pharmaceuticals Androgen and Anabolic Steroid Product Portfolio
6.10.5 Solvay Pharmaceuticals Recent Developments/Updates
6.11 Bausch Health
6.11.1 Bausch Health Corporation Information
6.11.2 Bausch Health Androgen and Anabolic Steroid Description and Business Overview
6.11.3 Bausch Health Androgen and Anabolic Steroid Sales, Revenue and Gross Margin (2018-2024)
6.11.4 Bausch Health Androgen and Anabolic Steroid Product Portfolio
6.11.5 Bausch Health Recent Developments/Updates
6.12 Pharmacia and Upjohn
6.12.1 Pharmacia and Upjohn Corporation Information
6.12.2 Pharmacia and Upjohn Androgen and Anabolic Steroid Description and Business Overview
6.12.3 Pharmacia and Upjohn Androgen and Anabolic Steroid Sales, Revenue and Gross Margin (2018-2024)
6.12.4 Pharmacia and Upjohn Androgen and Anabolic Steroid Product Portfolio
6.12.5 Pharmacia and Upjohn Recent Developments/Updates
6.13 Upsher-Smith
6.13.1 Upsher-Smith Corporation Information
6.13.2 Upsher-Smith Androgen and Anabolic Steroid Description and Business Overview
6.13.3 Upsher-Smith Androgen and Anabolic Steroid Sales, Revenue and Gross Margin (2018-2024)
6.13.4 Upsher-Smith Androgen and Anabolic Steroid Product Portfolio
6.13.5 Upsher-Smith Recent Developments/Updates
6.14 Clarus Therapeutics
6.14.1 Clarus Therapeutics Corporation Information
6.14.2 Clarus Therapeutics Androgen and Anabolic Steroid Description and Business Overview
6.14.3 Clarus Therapeutics Androgen and Anabolic Steroid Sales, Revenue and Gross Margin (2018-2024)
6.14.4 Clarus Therapeutics Androgen and Anabolic Steroid Product Portfolio
6.14.5 Clarus Therapeutics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Androgen and Anabolic Steroid Industry Chain Analysis
7.2 Androgen and Anabolic Steroid Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Androgen and Anabolic Steroid Production Mode & Process
7.4 Androgen and Anabolic Steroid Sales and Marketing
7.4.1 Androgen and Anabolic Steroid Sales Channels
7.4.2 Androgen and Anabolic Steroid Distributors
7.5 Androgen and Anabolic Steroid Customers
8 Androgen and Anabolic Steroid Market Dynamics
8.1 Androgen and Anabolic Steroid Industry Trends
8.2 Androgen and Anabolic Steroid Market Drivers
8.3 Androgen and Anabolic Steroid Market Challenges
8.4 Androgen and Anabolic Steroid Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Androgen and Anabolic Steroid Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Androgen and Anabolic Steroid Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Androgen and Anabolic Steroid Market Competitive Situation by Manufacturers in 2022
Table 4. Global Androgen and Anabolic Steroid Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Androgen and Anabolic Steroid Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Androgen and Anabolic Steroid Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Androgen and Anabolic Steroid Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Androgen and Anabolic Steroid Average Price (US$/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Androgen and Anabolic Steroid, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Androgen and Anabolic Steroid, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Androgen and Anabolic Steroid, Product Type & Application
Table 12. Global Key Manufacturers of Androgen and Anabolic Steroid, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Androgen and Anabolic Steroid by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Androgen and Anabolic Steroid as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Androgen and Anabolic Steroid Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Androgen and Anabolic Steroid Sales by Region (2018-2024) & (K Units)
Table 18. Global Androgen and Anabolic Steroid Sales Market Share by Region (2018-2024)
Table 19. Global Androgen and Anabolic Steroid Sales by Region (2024-2029) & (K Units)
Table 20. Global Androgen and Anabolic Steroid Sales Market Share by Region (2024-2029)
Table 21. Global Androgen and Anabolic Steroid Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Androgen and Anabolic Steroid Revenue Market Share by Region (2018-2024)
Table 23. Global Androgen and Anabolic Steroid Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Androgen and Anabolic Steroid Revenue Market Share by Region (2024-2029)
Table 25. North America Androgen and Anabolic Steroid Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Androgen and Anabolic Steroid Sales by Country (2018-2024) & (K Units)
Table 27. North America Androgen and Anabolic Steroid Sales by Country (2024-2029) & (K Units)
Table 28. North America Androgen and Anabolic Steroid Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Androgen and Anabolic Steroid Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Androgen and Anabolic Steroid Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Androgen and Anabolic Steroid Sales by Country (2018-2024) & (K Units)
Table 32. Europe Androgen and Anabolic Steroid Sales by Country (2024-2029) & (K Units)
Table 33. Europe Androgen and Anabolic Steroid Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Androgen and Anabolic Steroid Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Androgen and Anabolic Steroid Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Androgen and Anabolic Steroid Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Androgen and Anabolic Steroid Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Androgen and Anabolic Steroid Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Androgen and Anabolic Steroid Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Androgen and Anabolic Steroid Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Androgen and Anabolic Steroid Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Androgen and Anabolic Steroid Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Androgen and Anabolic Steroid Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Androgen and Anabolic Steroid Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Androgen and Anabolic Steroid Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Androgen and Anabolic Steroid Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Androgen and Anabolic Steroid Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Androgen and Anabolic Steroid Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Androgen and Anabolic Steroid Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Androgen and Anabolic Steroid Sales (K Units) by Type (2018-2024)
Table 51. Global Androgen and Anabolic Steroid Sales (K Units) by Type (2024-2029)
Table 52. Global Androgen and Anabolic Steroid Sales Market Share by Type (2018-2024)
Table 53. Global Androgen and Anabolic Steroid Sales Market Share by Type (2024-2029)
Table 54. Global Androgen and Anabolic Steroid Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Androgen and Anabolic Steroid Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Androgen and Anabolic Steroid Revenue Market Share by Type (2018-2024)
Table 57. Global Androgen and Anabolic Steroid Revenue Market Share by Type (2024-2029)
Table 58. Global Androgen and Anabolic Steroid Price (US$/Unit) by Type (2018-2024)
Table 59. Global Androgen and Anabolic Steroid Price (US$/Unit) by Type (2024-2029)
Table 60. Global Androgen and Anabolic Steroid Sales (K Units) by Application (2018-2024)
Table 61. Global Androgen and Anabolic Steroid Sales (K Units) by Application (2024-2029)
Table 62. Global Androgen and Anabolic Steroid Sales Market Share by Application (2018-2024)
Table 63. Global Androgen and Anabolic Steroid Sales Market Share by Application (2024-2029)
Table 64. Global Androgen and Anabolic Steroid Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Androgen and Anabolic Steroid Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Androgen and Anabolic Steroid Revenue Market Share by Application (2018-2024)
Table 67. Global Androgen and Anabolic Steroid Revenue Market Share by Application (2024-2029)
Table 68. Global Androgen and Anabolic Steroid Price (US$/Unit) by Application (2018-2024)
Table 69. Global Androgen and Anabolic Steroid Price (US$/Unit) by Application (2024-2029)
Table 70. Auxilium Pharmaceuticals Corporation Information
Table 71. Auxilium Pharmaceuticals Description and Business Overview
Table 72. Auxilium Pharmaceuticals Androgen and Anabolic Steroid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 73. Auxilium Pharmaceuticals Androgen and Anabolic Steroid Product
Table 74. Auxilium Pharmaceuticals Recent Developments/Updates
Table 75. AbbVie Corporation Information
Table 76. AbbVie Description and Business Overview
Table 77. AbbVie Androgen and Anabolic Steroid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 78. AbbVie Androgen and Anabolic Steroid Product
Table 79. AbbVie Recent Developments/Updates
Table 80. Teva Corporation Information
Table 81. Teva Description and Business Overview
Table 82. Teva Androgen and Anabolic Steroid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 83. Teva Androgen and Anabolic Steroid Product
Table 84. Teva Recent Developments/Updates
Table 85. GlaxoSmithKline Corporation Information
Table 86. GlaxoSmithKline Description and Business Overview
Table 87. GlaxoSmithKline Androgen and Anabolic Steroid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 88. GlaxoSmithKline Androgen and Anabolic Steroid Product
Table 89. GlaxoSmithKline Recent Developments/Updates
Table 90. Endo Pharmaceuticals Corporation Information
Table 91. Endo Pharmaceuticals Description and Business Overview
Table 92. Endo Pharmaceuticals Androgen and Anabolic Steroid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 93. Endo Pharmaceuticals Androgen and Anabolic Steroid Product
Table 94. Endo Pharmaceuticals Recent Developments/Updates
Table 95. Pfizer Corporation Information
Table 96. Pfizer Description and Business Overview
Table 97. Pfizer Androgen and Anabolic Steroid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 98. Pfizer Androgen and Anabolic Steroid Product
Table 99. Pfizer Recent Developments/Updates
Table 100. Acerus Pharmaceuticals Corporation Information
Table 101. Acerus Pharmaceuticals Description and Business Overview
Table 102. Acerus Pharmaceuticals Androgen and Anabolic Steroid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 103. Acerus Pharmaceuticals Androgen and Anabolic Steroid Product
Table 104. Acerus Pharmaceuticals Recent Developments/Updates
Table 105. Antares Pharma Corporation Information
Table 106. Antares Pharma Description and Business Overview
Table 107. Antares Pharma Androgen and Anabolic Steroid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 108. Antares Pharma Androgen and Anabolic Steroid Product
Table 109. Antares Pharma Recent Developments/Updates
Table 110. Amneal Pharmaceuticals Corporation Information
Table 111. Amneal Pharmaceuticals Description and Business Overview
Table 112. Amneal Pharmaceuticals Androgen and Anabolic Steroid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. Amneal Pharmaceuticals Androgen and Anabolic Steroid Product
Table 114. Amneal Pharmaceuticals Recent Developments/Updates
Table 115. Solvay Pharmaceuticals Corporation Information
Table 116. Solvay Pharmaceuticals Description and Business Overview
Table 117. Solvay Pharmaceuticals Androgen and Anabolic Steroid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 118. Solvay Pharmaceuticals Androgen and Anabolic Steroid Product
Table 119. Solvay Pharmaceuticals Recent Developments/Updates
Table 120. Bausch Health Corporation Information
Table 121. Bausch Health Description and Business Overview
Table 122. Bausch Health Androgen and Anabolic Steroid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 123. Bausch Health Androgen and Anabolic Steroid Product
Table 124. Bausch Health Recent Developments/Updates
Table 125. Pharmacia and Upjohn Corporation Information
Table 126. Pharmacia and Upjohn Description and Business Overview
Table 127. Pharmacia and Upjohn Androgen and Anabolic Steroid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 128. Pharmacia and Upjohn Androgen and Anabolic Steroid Product
Table 129. Pharmacia and Upjohn Recent Developments/Updates
Table 130. Upsher-Smith Corporation Information
Table 131. Upsher-Smith Description and Business Overview
Table 132. Upsher-Smith Androgen and Anabolic Steroid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 133. Upsher-Smith Androgen and Anabolic Steroid Product
Table 134. Upsher-Smith Recent Developments/Updates
Table 135. Clarus Therapeutics Corporation Information
Table 136. Clarus Therapeutics Description and Business Overview
Table 137. Clarus Therapeutics Androgen and Anabolic Steroid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 138. Clarus Therapeutics Androgen and Anabolic Steroid Product
Table 139. Clarus Therapeutics Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Androgen and Anabolic Steroid Distributors List
Table 143. Androgen and Anabolic Steroid Customers List
Table 144. Androgen and Anabolic Steroid Market Trends
Table 145. Androgen and Anabolic Steroid Market Drivers
Table 146. Androgen and Anabolic Steroid Market Challenges
Table 147. Androgen and Anabolic Steroid Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Androgen and Anabolic Steroid
Figure 2. Global Androgen and Anabolic Steroid Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Androgen and Anabolic Steroid Market Share by Type in 2022 & 2029
Figure 4. Testosterone Product Picture
Figure 5. Methyltestosterone Product Picture
Figure 6. Fluoxymesterone Product Picture
Figure 7. Others Product Picture
Figure 8. Global Androgen and Anabolic Steroid Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 9. Global Androgen and Anabolic Steroid Market Share by Application in 2022 & 2029
Figure 10. Hospitals
Figure 11. Pharmacy
Figure 12. Others
Figure 13. Global Androgen and Anabolic Steroid Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Androgen and Anabolic Steroid Market Size (2018-2029) & (US$ Million)
Figure 15. Global Androgen and Anabolic Steroid Sales (2018-2029) & (K Units)
Figure 16. Global Androgen and Anabolic Steroid Average Price (US$/Unit) & (2018-2029)
Figure 17. Androgen and Anabolic Steroid Report Years Considered
Figure 18. Androgen and Anabolic Steroid Sales Share by Manufacturers in 2022
Figure 19. Global Androgen and Anabolic Steroid Revenue Share by Manufacturers in 2022
Figure 20. The Global 5 and 10 Largest Androgen and Anabolic Steroid Players: Market Share by Revenue in 2022
Figure 21. Androgen and Anabolic Steroid Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 22. Global Androgen and Anabolic Steroid Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 23. North America Androgen and Anabolic Steroid Sales Market Share by Country (2018-2029)
Figure 24. North America Androgen and Anabolic Steroid Revenue Market Share by Country (2018-2029)
Figure 25. United States Androgen and Anabolic Steroid Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Canada Androgen and Anabolic Steroid Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Europe Androgen and Anabolic Steroid Sales Market Share by Country (2018-2029)
Figure 28. Europe Androgen and Anabolic Steroid Revenue Market Share by Country (2018-2029)
Figure 29. Germany Androgen and Anabolic Steroid Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. France Androgen and Anabolic Steroid Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. U.K. Androgen and Anabolic Steroid Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Italy Androgen and Anabolic Steroid Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Russia Androgen and Anabolic Steroid Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Asia Pacific Androgen and Anabolic Steroid Sales Market Share by Region (2018-2029)
Figure 35. Asia Pacific Androgen and Anabolic Steroid Revenue Market Share by Region (2018-2029)
Figure 36. China Androgen and Anabolic Steroid Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Japan Androgen and Anabolic Steroid Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. South Korea Androgen and Anabolic Steroid Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. India Androgen and Anabolic Steroid Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Australia Androgen and Anabolic Steroid Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. China Taiwan Androgen and Anabolic Steroid Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Indonesia Androgen and Anabolic Steroid Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Thailand Androgen and Anabolic Steroid Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Malaysia Androgen and Anabolic Steroid Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Latin America Androgen and Anabolic Steroid Sales Market Share by Country (2018-2029)
Figure 46. Latin America Androgen and Anabolic Steroid Revenue Market Share by Country (2018-2029)
Figure 47. Mexico Androgen and Anabolic Steroid Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Brazil Androgen and Anabolic Steroid Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Argentina Androgen and Anabolic Steroid Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Middle East & Africa Androgen and Anabolic Steroid Sales Market Share by Country (2018-2029)
Figure 51. Middle East & Africa Androgen and Anabolic Steroid Revenue Market Share by Country (2018-2029)
Figure 52. Turkey Androgen and Anabolic Steroid Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Androgen and Anabolic Steroid Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. UAE Androgen and Anabolic Steroid Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. Global Sales Market Share of Androgen and Anabolic Steroid by Type (2018-2029)
Figure 56. Global Revenue Market Share of Androgen and Anabolic Steroid by Type (2018-2029)
Figure 57. Global Androgen and Anabolic Steroid Price (US$/Unit) by Type (2018-2029)
Figure 58. Global Sales Market Share of Androgen and Anabolic Steroid by Application (2018-2029)
Figure 59. Global Revenue Market Share of Androgen and Anabolic Steroid by Application (2018-2029)
Figure 60. Global Androgen and Anabolic Steroid Price (US$/Unit) by Application (2018-2029)
Figure 61. Androgen and Anabolic Steroid Value Chain
Figure 62. Androgen and Anabolic Steroid Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed